Trials / Conditions / Pancreatic Neuroendocrine Tumor G2
Pancreatic Neuroendocrine Tumor G2
4 registered clinical trials studyying Pancreatic Neuroendocrine Tumor G2 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreati NCT06016855 | Vanderbilt-Ingram Cancer Center | Phase 4 |
| Completed | Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be NCT02893930 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Me NCT01229943 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Real-world Study on Adjuvant Octreotide Therapy in pNETs NCT06080204 | Changhai Hospital | N/A |